377 related articles for article (PubMed ID: 31333014)
21. Engineered Theranostic Magnetic Nanostructures: Role of Composition and Surface Coating on Magnetic Resonance Imaging Contrast and Thermal Activation.
Nandwana V; Ryoo SR; Kanthala S; De M; Chou SS; Prasad PV; Dravid VP
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6953-61. PubMed ID: 26936392
[TBL] [Abstract][Full Text] [Related]
22. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
23. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
24. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
25. Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy.
Zhang M; Cao Y; Wang L; Ma Y; Tu X; Zhang Z
ACS Appl Mater Interfaces; 2015 Mar; 7(8):4650-8. PubMed ID: 25672225
[TBL] [Abstract][Full Text] [Related]
26. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
[TBL] [Abstract][Full Text] [Related]
27. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY
Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802
[TBL] [Abstract][Full Text] [Related]
28. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
[TBL] [Abstract][Full Text] [Related]
29. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
30. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
[TBL] [Abstract][Full Text] [Related]
31. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
[TBL] [Abstract][Full Text] [Related]
32. Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy.
Hu D; Chen L; Qu Y; Peng J; Chu B; Shi K; Hao Y; Zhong L; Wang M; Qian Z
Theranostics; 2018; 8(6):1558-1574. PubMed ID: 29556341
[TBL] [Abstract][Full Text] [Related]
33. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
34. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
35. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
38. Pegylated and amphiphilic Chitosan coated manganese ferrite nanoparticles for pH-sensitive delivery of methotrexate: Synthesis and characterization.
Karimi Z; Abbasi S; Shokrollahi H; Yousefi G; Fahham M; Karimi L; Firuzi O
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():504-511. PubMed ID: 27987737
[TBL] [Abstract][Full Text] [Related]
39. Amplifying Apoptosis Homing Nanoplatform for Tumor Theranostics.
Zhao H; Zhou P; Huang K; Deng G; Zhou Z; Wang J; Wang M; Zhang Y; Yang H; Yang S
Adv Healthc Mater; 2018 Jul; 7(14):e1800296. PubMed ID: 29745029
[TBL] [Abstract][Full Text] [Related]
40. Platelet-camouflaged nanococktail: Simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy.
Jing L; Qu H; Wu D; Zhu C; Yang Y; Jin X; Zheng J; Shi X; Yan X; Wang Y
Theranostics; 2018; 8(10):2683-2695. PubMed ID: 29774068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]